Over-the-counter (OTC) teething products containing benzocaine have raised significant health concerns. Benzocaine, a commonly used numbing agent, has been linked to severe risks in infants and young children, including life-threatening conditions. As an FDA approved laboratory, MAS emphasizes the importance of rigorous testing to ensure the safety of children’s products. 

Why FDA Approved Laboratories Are Vital for Testing Children's Teething Products

Benzocaine in teething products poses serious risks, highlighting the need for laboratory testing to ensure compliance. The FDA has issued warnings about benzocaine, citing its potential to cause methemoglobinemia, a blood disorder that reduces oxygen levels in the bloodstream. This condition can result in symptoms such as difficulty breathing, fatigue, and, in severe cases, death. Infants are particularly vulnerable, as their smaller bodies absorb chemicals more rapidly. The FDA has urged parents to avoid OTC teething gels containing benzocaine entirely.

FDA approved laboratories like MAS play a critical role in identifying harmful ingredients in teething products. By conducting thorough testing, MAS helps manufacturers ensure their products comply with federal safety guidelines, mitigating risks before products reach consumers.

The Role of FDA Approved Laboratories in Public Health

MAS testing services ensure safe formulations by detecting harmful ingredients like benzocaine. As highlighted by the FDA, approved laboratories are essential in identifying potential risks in children’s products. MAS offers comprehensive analysis of active ingredients, ensuring chemicals like benzocaine are either eliminated or do not exceed safe levels. This testing allows manufacturers to adjust formulations to prioritize safety.

Untested natural remedies for teething pain also pose risks, as they may lack essential safety data. Parents are encouraged to explore safer alternatives, such as gently massaging gums or using chilled teething rings. 

MAS and FDA Approved Laboratories: Safeguarding Children 

MAS helps manufacturers bring safer products to market through detailed testing and compliance support. The FDA’s stance on benzocaine is clear—OTC teething products containing this compound should be removed. By partnering with MAS, manufacturers can conduct rigorous testing to prevent the use of unsafe ingredients. This proactive approach not only protects public health but also strengthens trust in product safety.

MAS’s expertise in regulatory testing ensures manufacturers meet federal safety standards. From benzocaine testing to compliance support, MAS provides critical insights that help companies develop safer formulations. 

Ensuring Compliance and Safety with MAS

Partnering with MAS gives manufacturers confidence in meeting safety and compliance standards. For manufacturers producing teething products, MAS offers comprehensive testing services that identify harmful ingredients like benzocaine and provide guidance for safer alternatives. 

Contact MAS today to learn how our laboratory can help you meet the highest safety standards. Visit our website for more information or explore our blog on safe product testing for children.

Sources:

1. FDA Takes Action Against Use of OTC Benzocaine Teething Products Due to Serious Safety Risk, Lack of Benefit - https://www.fda.gov/news-events/press-announcements/fda-takes-action-against-use-otc-benzocaine-teething-products-due-serious-safety-risk-lack-benefit
2. Risk of Serious and Potentially Fatal Blood Disorder Prompts FDA Action on Oral Over-the-Counter Benzocaine - https://www.fda.gov/drugs/drug-safety-and-availability/risk-serious-and-potentially-fatal-blood-disorder-prompts-fda-action-oral-over-counter-benzocaine
3. Safely Soothing Teething Pain in Infants and Children | FDA - https://www.fda.gov/consumers/consumer-updates/safely-soothing-teething-pain-infants-and-children